Investment Stage

Focus Areas

About Investor

Lorna Collings serves as Chief Financial Officer at ALSA Ventures in London, where she focuses on investments in life science, pharmaceutical, therapeutics, and biotechnology sectors, with typical investment ranges between $100K - $5.0M. Lorna brings more than twenty years of experience in private equity and venture capital, having previously worked at EQT and Hermes GPE in finance and consultancy roles within the private equity industry. ALSA Ventures is a UK/Europe focused biotechnology investment firm that invests in novel therapeutics at preclinical proof of concept or early clinical development stages. Lorna's extensive background in finance and her BA (Hons) degree in Applied Psychology from Sussex University provide her with unique insights into both the financial and human aspects of venture capital investments.